RLMD - Relmada Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

RLMD is currently covered by 1 analysts with an average price target of $19. This is a potential upside of $16.38 (625.19%) from yesterday's end of day stock price of $2.62.

Relmada Therapeutics's activity chart (see below) currently has 42 price targets and 48 ratings on display. The stock rating distribution of RLMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 17.36% of the time, taking 89.23 days on average.

Highest price target for RLMD is $19, Lowest price target is $19, average price target is $19.

Most recent stock forecast was given by UY EAR from MIZUHO on 08-Apr-2026. First documented stock forecast 15-Dec-2019.

Best performing analysts who are covering RLMD - Relmada Therapeutics:

Marc Goodman Uy Ear James Lee Andrew Tsai Yatin Suneja Jay Olson Vamil Divan Andrea Tan

Currently out of the existing stock ratings of RLMD, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Mar-2026

$19

$16.38 (625.19%)

7 months 13 days ago
(08-Apr-2026)

2/11 (18.18%)

$11.99 (171.04%)

236

Buy Since 10-Jan-2020

$1

$10

1 years 11 months 17 days ago
(04-Dec-2024)

2/6 (33.33%)

$0.37 (58.73%)

158

Buy Since 16-Nov-2021

$25

2 years 13 days ago
(07-Nov-2024)

0/5 (0%)

$21.73 (664.53%)

Hold Since 17-Sep-2024

$13

$75

2 years 2 months 4 days ago
(17-Sep-2024)

0/3 (0%)

$9.56 (277.91%)

Hold Since 05-Jun-2024

$2

2 years 5 months 16 days ago
(05-Jun-2024)

1/2 (50%)

$-0.96 (-32.43%)

182

Show more analysts

Please expand the browser size to see the chart

What is RLMD (Relmada Therapeutics) average time for price targets to be met?

On average it took 89 days for the stock forecasts to be reached, with an average price target met ratio of 17.36%.

Which analyst most recently updated their price target on RLMD (Relmada Therapeutics)?

Uy Ear

Which analyst has the most public recommendations on RLMD (Relmada Therapeutics)?

Uy Ear works at MIZUHO and has 3 price targets and 3 ratings on RLMD

Which analyst is the currently most bullish on RLMD (Relmada Therapeutics)?

Ross Weinreb with the highest potential upside of $65.38

Which analyst is the currently most reserved on RLMD (Relmada Therapeutics)?

Marc Goodman with the lowest potential downside of -$5.69
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?